OCBCO
EW icon

Oversea-Chinese Banking Corp (OCBC)’s Edwards Lifesciences EW Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,448
Closed -$239K – 346
2023
Q3 		$239K Hold
3,448
– – 0.01% 345
2023
Q2 		$325K Hold
3,448
– – 0.02% 265
2023
Q1 		$285K Buy
3,448
+644
+23% +$50.6K 0.01% 271
2022
Q4 		$209K Buy
+2,804
New +$216K 0.01% 328

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Oversea-Chinese Banking Corp (OCBC)'s EW Position: Q4 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 3,448 shares — an estimated $239K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in EW in Q4 2022 and held it in 4 quarters. The position peaked at $325K in Q2 2023. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 3,448 Edwards Lifesciences shares in Q4 2023, an estimated $239K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Edwards Lifesciences in Q4 2022 and held it in 4 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s Edwards Lifesciences position peaked at $325K in Q2 2023.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q4 2023, filed 1 Feb 2024.